Predictors of atrial fibrillation after coronary artery bypass surgery

Coronary Artery Disease

Volumn 18, Issue 5, 2007, Pages 327-331

  Dogan, Sait Mesut ^a   Buyukates, Mustafa ^a   Kandemir, Ozer ^a   Aydin, Mustafa ^a   Gursurer, Metin ^a   Acikgoz, Serefden ^a   Yavuzer, Rale ^a   Cam, Fatih ^a   Dursun, Aydin ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Atrial enlargement; Atrial fibrillation; Coronary artery bypass surgery; Dispersion; N terminal proBrain natriuretic peptide; P wave; Predictor

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGE; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD SAMPLING; CALCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORRELATION ANALYSIS; DEMOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; LABORATORY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; P WAVE; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINUS RHYTHM; UNIVARIATE ANALYSIS; VENOUS BLOOD;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS; CORONARY STENOSIS; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS;

EID: 34547523347     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3281689a2c     Document Type: Article

References (24)

1. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, et al. Predictors of atrial fibrillation after coronary artery surgery. Circulation 1996; 94:390-397.
2. Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG, et al. Atrial fibrillation after cardiac surgery. A major morbid event? Ann Surg 1997; 4:501-513.
3. Mathew JP, Parks R, Savino JS, Friedman AS, Koch C, Mangano DT, et al. Atrial fibrillation following coronary artery bypass surgery. Predictors, outcome and resource utilization. J Am Med Assoc 1996; 276:306.
4. Fuller JA, Adams GG, Buxton B. Atrial fibrillation after coronary artery bypass grafting: is it a disorder of the elderly? J Thorac Cardiovasc Surg 1989; 97:821-825.
5. Leitch JW, Thomson D, Baird DK, Harris PJ. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1990; 100:338-342.
6. Wazni OM, Martin DO, Marrouche NF, Latif AA, Ziada K, Shaaraoui M, et al. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 2004;110:124-127.
7. Hakala T, Hedman A, Turpeinen A, Kettunen R, Vuolteenaho O, Hippeläinen M. Prediction of atrial fibrillation after coronary artery bypass grafting by measuring atrial peptide levels and preoperative atrial dimensions. Eur J Cardiothorac Surg 2002;22:939-943.
8. Budeus M, Hennersdorf M, Röhlen S, Schnitzler S, Felix O, Reimert K, et al. Prediction of atrial fibrillation after coronary artery bypass grafting: the role of chemoreflexsensitivity and P wave signal averaged ECG. Int J Cardiol 2006; 106:67-74.
9. Dilaveris P, Gialafos EJ, Sideris S, Theopistou AM, Andrikopoulos GK, Kyriakidis M, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998;135:733-738.
10. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
11. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2:358-364.
12. Aytemir K, Ozer N, Atalar E, Sade E, Aksöyek S, + Ovünç K, et al. P-wave Dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. PACE 2000; 23:1109-1112.
13. Dilaveris PE, Gialafos EJ, Andrikopoulos GK, Richter DJ, Papanikolaou V, Poralis K, Giafolos JE. Clinical and electrocardiographic predictors of recurrent atrial fibrillation. PACE 2000; 23:352-358.
14. Ozer N, Aytemir K, Atalar E, Sade E, Aksöyek S, + Ovünç K, et al. P wave dispersion in hypertensive patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000; 23:1859-1862.
15. Fareh S, Villemaire C, Nattel S. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. Circulation 1998;98:2202-2209.
16. Yilmaz R, Demirbag R. P-wave dispersion in patients with stable coronary artery disease and its relationship with severity of the disease. J Electrocardiol 2005;38:279-284.
17. Dilaveris PE, Andrikopoulos GK, Metaxas G, Richter DJ, Avgeropoulou CK, Androulakis AM, et al. Effects of ischemia on P wave dispersion and maximum P wave duration during spontaneous anginal episodes. Pacing Clin Electrophysiol 1999; 22:1640-1647.
18. Dogan SM, Yildirim N, Gursurer M, Aydin M, Kalaycioglu E, Cam F. P-wave duration and dispersion in patients with coronary slow flow and its relationship with thrombolysis in myocardial infarction frame count. J Electrocardiol 2007; in press.
19. Silvet H, Young-Xu Y, Walleigh D, Ravid S. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 2003; 92:1124-1127.
20. Ellinor PT, Low AF, Patton KK, Shea MA, MacRae CM. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol 2005;45:82-86.
21. Nakao K, Mukoyama M, Hosoda K, Shin-Ichi S, Ogawa Y, Saito Y, et al. Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide. Can J Physiol Pharmacol 1991; 69:1500-1506.
22. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96:1180-1184.
23. Nishigaki K, Tomita M, Kagawa K, Noda T, Minatoguchi S, Oda H, et al. Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1996; 28:1234-1242.
24. Wieczorek SJ, Wu AH, Christenson R, Krishnaswamy P, Gottlieb S, Rosano T, et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J 2002; 144:834-839.